CAS: 1342276-76-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea REF: AN-AG009W9UCAS: 1342276-76-9 | 99% | 152,00 €~616,00 € | Jue 09 May 24 |
 | RKI1313 REF: TM-T2011CAS: 1342276-76-9 | 99.06% | 230,00 €~2.233,00 € | Jue 16 May 24 |
 | RKI-1313 REF: 3D-SDC27676CAS: 1342276-76-9 | Min. 95% | A consultar | Jue 20 Jun 24 |
1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea
CAS:1342276-76-9
Fórmula:
C17H16N4O2S
Pureza:
99%
Peso molecular:
340.3995
Ref: AN-AG009W9U
| 5mg | 152,00 € | |
| 25mg | 616,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
RKI1313
CAS:1342276-76-9
RKI1313 (RKI-1313) was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, …
Fórmula:
C17H16N4O2S
Pureza:
99.06%
Forma y color:
Solid
Peso molecular:
340.4
Ref: TM-T2011
| 1mg | 230,00 € | |
| 2mg | 342,00 € | |
| 5mg | 573,00 € | |
| 10mg | 817,00 € | |
| 25mg | 1.234,00 € | |
| 50mg | 1.672,00 € | |
| 100mg | 2.233,00 € | |
| 1ml*10 (DMSO) | 557,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
RKI-1313
CAS:1342276-76-9
RKI-1313 is an analog of RKI-1447 that is more potent as an inhibitor of ROCK1 …
Fórmula:
C17H16N4O2S
Pureza:
Min. 95%
Peso molecular:
340.4 g/mol
Ref: 3D-SDC27676
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
